QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文 LANCET ONCOLOGY, 2017, 卷号: 18, 期号: 3 作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei 收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05 Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 42 作者:  Liu, Yun;  Ye, Guoxin;  Yan, Dali;  Zhang, Lei;  Fan, Fan 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 nab-paclitaxel  taxanes  chemotherapy  breast cancer  meta-analysis   Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer： a randomized controlled trial 期刊论文 Chinese Journal of Cancer, 2017, 卷号: 第36卷, 页码: P274-281 作者:  Tan Qiuwen;  Luo Ting;  Zheng Hong;  Tian Tinglun;  He Ping 收藏  |  浏览/下载：12/0  |  提交时间：2019/02/28 Locally advanced breast cancer　　Neoadjuvant　　Randomized clinical trial　　Taxanes　　Anthracycline　　Chemotherapy   Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文 The Lancet Oncology, 2017, 卷号: Vol.18 No.3, 页码: 371-383 作者:  Zhang, P.;  Sun, T.;  Zhang, Q.;  Yuan, Z.;  Jiang, Z. 收藏  |  浏览/下载：5/0  |  提交时间：2019/02/25 Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文 LANCET ONCOLOGY, 2017, 卷号: 18, 期号: 3, 页码: 371-383 作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11 Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文 2017, 卷号: 18, 期号: 3, 页码: 371-383 作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei 收藏  |  浏览/下载：12/0  |  提交时间：2020/01/04 Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy 期刊论文 CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29 - 收藏  |  浏览/下载：15/0  |  提交时间：2020/10/26 PAINFUL DIABETIC-NEUROPATHY  DOUBLE-BLIND  PLACEBO  PREVENTION  MANAGEMENT  TRIAL  GABAPENTIN  PREGABALIN  ONCOLOGY  TAXANES  Duloxetine  FACT-Tax Scales  paclitaxel  peripheral neuropathy